Pedro M. García-Barrantes

Author

Vanderbilt University ORCID

Also Known As

Pedro M. Garcia-Barrantes, Pedro M. Garcia‐Barrantes, Pedro M. García-Barrantes, Pedro Manuel García-Barrantes

Publications

855

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center John F. Kennedy Center for the Performing Arts Universidad de Costa Rica

About

Pedro M. García-Barrantes is an author at Vanderbilt University specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	530
2	Social Sciences	4	4	179
3	Natural Sciences	3	3	374
4	Biochemistry	2	2	72
5	Health Sciences	1	1	14

Pedro M. García-Barrantes

Publications

836

Citations

H-Index

Page 1

	Year	Citations
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design Anders Friberg, Dominico Vigil, Bin Zhao, Journal of Medicinal Chemistry Lead CompoundsDrug TargetLarge Fragment LibraryMolecular BiologyChemical Biology	2012	302
A Novel M <sub>1</sub> PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity Jerri M. Rook, Jeanette L. Bertron, Hyekyung P. Cho, ACS Chemical Neuroscience	2018	63
Synthesis and biological evaluation of novel ferrocene–naphthoquinones as antiplasmodial agents Pedro M. García-Barrantes, Guy Lamoureux, Alice L. Pérez, European Journal of Medicinal Chemistry Bioorganic ChemistryBiochemistryNatural SciencesOrganic ChemistryNovel Ferrocene–naphthoquinones	2013	60
Diverse Effects on M<sub>1</sub> Signaling and Adverse Effect Liability within a Series of M<sub>1</sub> Ago-PAMs Jerri M. Rook, Masahito Abe, Hyekyung P. Cho, ACS Chemical Neuroscience	2016	56
Chemical Modulation of Mutant mGlu<sub>1</sub> Receptors Derived from Deleterious <i>GRM1</i> Mutations Found in Schizophrenics Hyekyung P. Cho, Pedro M. García-Barrantes, John T. Brogan, ACS Chemical Biology Deleterious NssnpsSynaptic SignalingSocial SciencesMolecular PharmacologyPsychiatric Genetics	2014	54
Discovery of VU0409551/JNJ-46778212: An mGlu<sub>5</sub> Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia Susana Conde-Ceide, Carlos M. Martínez‐Viturro, Jesús Alcázar, ACS Medicinal Chemistry Letters Psychotropic MedicationMolecular BiologyPsychopharmacologyPharmacotherapySocial Sciences	2015	52
Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators Samantha E. Yohn, Daniel J. Foster, Dan P. Covey, Molecular Psychiatry PsychiatryFunctional SelectivityMedicineAntipsychotic-like EffectsPsychopharmacology	2018	50
Discovery, Synthesis, and Preclinical Characterization of<i>N</i>-(3-Chloro-4-fluorophenyl)-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>) Darren W. Engers, Anna L. Blobaum, Rocco D. Gogliotti, ACS Chemical Neuroscience	2016	45
Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu<sub>1</sub>), Based on an <i>N</i>-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu<sub>1</sub> Receptors Found in Schizophrenics Pedro M. García-Barrantes, Hyekyung P. Cho, Colleen M. Niswender, Journal of Medicinal Chemistry Synaptic TransmissionPeptide SciencePharmacotherapyExperimental PharmacologySocial Sciences	2015	23
Anti-ulcerogenic properties of Quassia amara L. (Simaroubaceae) standardized extracts in rodent models Pedro M. García-Barrantes, Beatriz Badilla Journal of Ethnopharmacology Medicinal ChemistryAnti-ulcerogenic PropertiesMedicineHerbal MedicineHerb-drug Interaction	2011	21

Page 1